entertainment -WSS

entertainment

author：hotspot 2025-09-28 15:55:17 - browse：46184

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Apple is now the first public company to be valued at $3 trillion

hotspot

WSS

ADCs take center stage as promising cancer treatments

As demand for Covid shots wanes, Moderna seeks its next success

After affirmative action ruling, medical educators look to 'holistic review'

What does generative AI mean for health care? We asked experts

The problems with dementia villages

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

focus

entertainment

A looming test for neoantigen cancer vaccines

hotspot

Virginia high school admissions case could be legal follow

The high cost of giving birth even with insurance

Hollywood unions extend contract negotiations for actors

How to save PrEP access — and even expand it

New air purifier tech could be key to improving indoor air quality

State Dept. review finds Biden bears some blame for Afghanistan failures

Affirmative action in medical school literally saved lives

Is there really a nursing shortage in the U.S.?

How to save PrEP access — and even expand it

STAT Summit: How researchers deal with rejection

Wikipedia

Roivant's CEO is a star, but biotech's black hole persists

Medical records are filled with copy

ChatGPT in medicine: STAT answers readers' burning questions

Medicare proposal to cover medical devices draws a mixed reaction

Medicare details structure of new drug price negotiation program

Apple is now the first public company to be valued at $3 trillion

leisure time

hotspot

hotspot

hotspot